Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BenefiGANO (Ganoderma lucidum GANO88) is a premium fungal fermented ingredient developed and manufactured by Syngen Biotech. Produced using deep liquid fermentation technology, it contains abundant bioactive polysaccharides, including beta-1,3-glucans, and a patented bioactive component known as vascular protection factor F5-2. BenefiGANO is designed as a dietary supplement ingredient to support immune health, liver wellness (hepatoprotection), cardiovascular health, and anti-fatigue and anti-inflammatory benefits. It is marketed for use in various formulations, including capsules, tablets, powders, and liquids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BenefiGANO.